Latest Biotech News

The FDA has approved Intellia Therapeutics’ in vivo CRISPR therapy for hereditary angioedema (HAE), clearing lonvoguran ziclumeran (lonvo-z) for the one-dose genome-editing approach following a...

HHS unveiled new programs designed to accelerate U.S. clinical development amid mounting competition from China and other regions. The initiative includes “Surpass,” a five-year effort to make...

Sanofi and Regeneron expanded their long-running antibody partnership with a deal worth up to $8 billion, adding four long-acting immunology candidates aimed at IL-13 and IL-4-related pathways....

Kallyope has rebranded as TriGemX Bio after its obesity deal involving Novo, shifting focus exclusively to migraine. The company also secured $94 million in financing, supporting Phase 3 work for...

A venture update reports that Kallyope became TriGemX after the Novo obesity deal, raising $94 million to pursue its migraine pipeline. The financing is framed as a way to support the restructured...

A roundup of upcoming FDA decisions for the fourth quarter of 2026 highlights potential inflection points for investors and clinicians. The brief points to anticipated decisions on a new cancer...

A prospective pilot study in Italy reports that gallium-68 labeled PSMA-11 PET/MR can illuminate disease in prostate cancer and help predict relapse timing. The report centers on imaging...

A French retrospective analysis reports real-world evidence for venetoclax in Waldenström macroglobulinemia, focusing on patients with disease return after standard treatments. The work indicates...

A prospective phase II trial from Korea reports data exploring a strategy that primes the immune system with a short, intense course before treatment in small cell lung cancer. The approach is...

In biopharmaceutical manufacturing, researchers report an engineered protein breakdown system designed to improve drug-free selection of high-producing CHO cells. The work targets one of the...

The FDA has approved Intellia Therapeutics’ in vivo CRISPR therapy for hereditary angioedema, clearing lonvoguran ziclumeran (lonvo-z) after a successful Phase 3 program. The approval supports a...

Sanofi and Regeneron expanded their long-running antibody collaboration, pledging $1 billion upfront to develop four next-generation, long-acting immunology candidates aimed at the Dupixent...

A large retrospective review reports that the checkpoint inhibitor nivolumab can trigger cytokine release syndrome (CRS), including severe and potentially deadly presentations. Published in...

Inha University researchers reported an engineered protein-breakdown strategy that improves drug-free selection of high-producing CHO cells. The approach targets a manufacturing bottleneck:...

A trio of studies highlights how AI is moving from screening concepts toward decision support in healthcare. One report describes an audio AI model for asthma that surpasses 96% accuracy, aiming...

New preclinical and translational imaging work focuses on improving how clinicians track and potentially treat solid tumors. A dual-target radioligand, INN02, delivered both enhanced tumor imaging...

Two reports underline how real-world biology and adverse-event tracking are shaping modern oncology decision-making. One case analysis describes how loneliness and complex health trajectories can...

A case-based clinical report describes lettermovir shielding a rare immunodeficiency patient through a multi-transplant and infection-heavy course. Published in Annals of Hematology, the report...

HHS announced new programs intended to speed US clinical development amid intensifying global competition. The initiatives include “Surpass,” designed to treat clinical development as a continuous...

Devoted Health announced nearly $1.2 billion in fresh funding after enrolling hundreds of thousands of new senior members. The financing includes a $555 million Series G tranche and positions the...